Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Mechanisms Responsible for Diastolic Dysfunction in Diabetes Mellitus Patients
Jovana Nikolajević Starčević, Miodrag Janić, Mišo Šabovič
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 5, pp. 1197-1197
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease
William B. Horton, Eugene J. Barrett
Endocrine Reviews (2020) Vol. 42, Iss. 1, pp. 29-55
Open Access | Times Cited: 226
Heart failure in diabetes
Stanislovas S. Jankauskas, Urna Kansakar, Fahimeh Varzideh, et al.
Metabolism (2021) Vol. 125, pp. 154910-154910
Open Access | Times Cited: 137
Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction
Yu-Chen Wang, Yen Chin Koay, Calvin Pan, et al.
Circulation Research (2024) Vol. 134, Iss. 4, pp. 371-389
Open Access | Times Cited: 47
Unlocking the Full Potential of SGLT2 Inhibitors: Expanding Applications beyond Glycemic Control
Mahmoud E. Youssef, Galal Yahya, Mihaela Simona Popoviciu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6039-6039
Open Access | Times Cited: 40
Telmisartan and thiorphan combination treatment attenuates fibrosis and apoptosis in preventing diabetic cardiomyopathy
Vajir Malek, Anil Bhanudas Gaikwad
Cardiovascular Research (2018) Vol. 115, Iss. 2, pp. 373-384
Open Access | Times Cited: 53
Role of the vascular endothelial sodium channel activation in the genesis of pathologically increased cardiovascular stiffness
Michael A. Hill, Frédéric Jaisser, James R. Sowers
Cardiovascular Research (2020) Vol. 118, Iss. 1, pp. 130-140
Open Access | Times Cited: 49
Syringaresinol Protects against Type 1 Diabetic Cardiomyopathy by Alleviating Inflammation Responses, Cardiac Fibrosis, and Oxidative Stress
Guangru Li, Lei Yang, Lifeng Feng, et al.
Molecular Nutrition & Food Research (2020) Vol. 64, Iss. 18
Closed Access | Times Cited: 48
Inhibition of Sodium Glucose Cotransporters Improves Cardiac Performance
Álvaro García‐Ropero, Ariana P. Vargas-Delgado, Carlos G. Santos‐Gallego, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3289-3289
Open Access | Times Cited: 43
Diabetic Cardiomiopathy Progression is Triggered by miR122-5p and Involves Extracellular Matrix
Riccardo Pofi, Elisa Giannetta, Nicola Galea, et al.
JACC. Cardiovascular imaging (2020) Vol. 14, Iss. 6, pp. 1130-1142
Open Access | Times Cited: 43
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions
Alfredo Caturano, Erica Vetrano, Raffaele Galiero, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10173-10173
Open Access | Times Cited: 4
Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness
Annayya R. Aroor, Srinivas Mummidi, Juan Carlos López-Alvarenga, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 24
A comprehensive review on diabetic cardiomyopathy (DCM): histological spectrum, diagnosis, pathogenesis, and management with conventional treatments and natural compounds
Ahmed R. Abdullah, Mahmoud A. Seliem, Emad Gamil Khidr, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
The Mechanical Role of YAP/TAZ in the Development of Diabetic Cardiomyopathy
Junxian Shen, Ling Zhang, Huan‐Huan Liu, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 5, pp. 297-297
Open Access
Myocardial Tissue Characterization in Heart Failure with Preserved Ejection Fraction: From Histopathology and Cardiac Magnetic Resonance Findings to Therapeutic Targets
Paolo Severino, Andrea D’Amato, Silvia Prosperi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7650-7650
Open Access | Times Cited: 22
Lipids and diastolic dysfunction: Recent evidence and findings
Padideh Daneii, Sina Neshat, Monir Sadat Mirnasiry, et al.
Nutrition Metabolism and Cardiovascular Diseases (2022) Vol. 32, Iss. 6, pp. 1343-1352
Closed Access | Times Cited: 16
<p>Alpha-Mangostin Improves Cardiac Hypertrophy and Fibrosis and Associated Biochemical Parameters in High-Fat/High-Glucose Diet and Low-Dose Streptozotocin Injection-Induced Type 2 Diabetic Rats</p>
Vivian Soetikno, Andriyani Murwantara, Prisma Andini, et al.
Journal of Experimental Pharmacology (2020) Vol. Volume 12, pp. 27-38
Open Access | Times Cited: 23
Gold Nanoparticles Ameliorate Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats
Alaa A. A. Aljabali, Bahaa Al‐Trad, Lina Al Gazo, et al.
Journal of Molecular Structure (2021) Vol. 1231, pp. 130009-130009
Open Access | Times Cited: 19
Novel oral edaravone attenuates diastolic dysfunction of diabetic cardiomyopathy by activating the Nrf2 signaling pathway
Ling Wang, Yue-Qin Zeng, Juan-Hua Gu, et al.
European Journal of Pharmacology (2022) Vol. 920, pp. 174846-174846
Open Access | Times Cited: 12
Impact of Sex and Diabetes in Patients with Heart Failure
Sara Álvarez-Zaballos, Manuel Martínez‐Sellés
Current Heart Failure Reports (2024) Vol. 21, Iss. 4, pp. 389-395
Closed Access | Times Cited: 2
Diabetic cardiomyopathy: pathophysiology, imaging assessment and therapeutical strategies.
Vincenzo Rizza, Lara Tondi, Angelo Maria Patti, et al.
International Journal of Cardiology Cardiovascular Risk and Prevention (2024) Vol. 23, pp. 200338-200338
Open Access | Times Cited: 2
Pathophysiology, Clinical Characteristics of Diabetic Cardiomyopathy: Therapeutic Potential of Natural Polyphenols
Neha Atale, Dhananjay Yadav, Vibha Rani, et al.
Frontiers in Nutrition (2020) Vol. 7
Open Access | Times Cited: 17
Fructose plus High-Salt Diet in Early Life Results in Salt-Sensitive Cardiovascular Changes in Mature Male Sprague Dawley Rats
Peter Levanovich, Charles S. Chung, Dragana Komnenov, et al.
Nutrients (2021) Vol. 13, Iss. 9, pp. 3129-3129
Open Access | Times Cited: 14
RBM20, a Therapeutic Target to Alleviate Myocardial Stiffness via Titin Isoforms Switching in HFpEF
Na Li, Weijian Hang, Hongyang Shu, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 10
Impact of preexisting diabetes mellitus on cardiovascular and all-cause mortality in patients with atrial fibrillation: A meta-analysis
Juan Xu, Yimeng Sun, Dandan Gong, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 10
Neutrophil: lymphocyte ratio is positively associated with subclinical diabetic cardiomyopathy
Xiaoli Huang, Zihan Qin, Min Xu, et al.
BMC Endocrine Disorders (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top